首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1392005

頸椎病治療市場：依治療類型、給藥途徑、配銷通路及地區

Cervical Spondylosis Treatment Market, By Type of Treatment (Medications and Surgery), By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年11月09日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年全球頸椎病治療市場規模為54億美元，預計2022年至2030年年複合成長率為5.6%，2030年達79億美元。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	54億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	5.60%	2030年市場規模預測	79億美元

圖 1. 2023 年按地區分類的頸椎病治療全球市場佔有率（%）

頸椎病是一種影響頸部的退化性疾病。頸椎（頸部）與老齡化相關的磨損的總稱，可導致頸部疼痛、頸部僵硬和其他症狀。它也被稱為關節炎或頸椎骨關節炎。這是頸部軟骨、椎間盤、韌帶和骨骼的自然磨損。這種情況很常見，並且隨著老齡化而惡化。在許多情況下，不需要特殊治療。如果出現症狀，治療可能包括藥物、皮質類固醇注射、物理治療，有時還包括手術。

市場動態：

頸椎病負擔的增加、頸背痛盛行率的上升、老年人口的增加以及全球對安全有效頸椎病治療的需求不斷增加正在推動全球頸椎病治療市場的成長。

例如，頸椎病變是老年人脊髓型頸椎病變的一個非常常見的原因。它是老年人中最常見的脊椎功能障礙。這種情況很常見，並且隨著老齡化而惡化。 60歲以上的老年人中，85%以上有頸椎病。因此，隨著老年人口的增加和頸椎病負擔的加重，對安全有效的頸椎病治療的需求也越來越大。據世界衛生組織（WHO）稱，到2030年，世界上六分之一的人將超過60歲，到2050年，世界60歲以上的人口將增加一倍（達到21億人）。

本研究的主要特點

本報告對全球頸椎病治療市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率。
它還強調了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據以下參數（例如公司亮點、產品系列、主要亮點、財務實績和策略）介紹了全球頸椎病治療市場的主要企業。
本研究涵蓋的主要企業包括輝瑞公司、雅培實驗室、阿斯特捷利康公司、諾華公司、默克公司、梯瓦製藥工業有限公司、安進公司、百時美施貴寶公司、禮來公司、葛蘭素史克公司、Johnson &Johnson Services, Inc.、Sanofi SA、Stryker Corporation、Zimmer Biomet Holdings, Inc. 和 Medtronic plc。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球頸椎病治療市場的各種策略矩陣來促進他們的決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
日本
印度
東南亞國協
澳洲
韓國
其他亞太地區
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
中部非洲
南非

第9章競爭形勢

Pfizer Inc.
Abbott Laboratories
AstraZeneca Plc.
Novartis AG
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Amgen Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Sanofi SA
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Medtronic plc

第10章

調查方法
關於出版商

簡介目錄

Product Code: CMI5710

The global cervical spondylosis treatment market size was valued at US$ 5.4 Billion in 2023 and is expected to reach US$ 7.9 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 5.4 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.60%	2030 Value Projection:	US$ 7.9 Bn

Figure 1. Global Cervical Spondylosis Treatment Market Share (%), By Region, 2023

Cervical Spondylosis Treatment Market - IMG1

Cervical spondylosis is a type of degenerative disease that affects the neck. It is a general term for age-related wear and tear in the cervical spine (neck) that can lead to neck pain, neck stiffness, and other symptoms. Sometimes this condition is called arthritis or osteoarthritis of the neck. It is the natural wearing down of cartilage, disks, ligaments, and bones in the neck. It is very common and worsens with age. In many cases, no specific treatment is required. If symptoms occur, treatments include medication, corticosteroid injections, physiotherapy, and sometimes surgery.

Market Dynamics:

Rising burden of cervical spondylosis, increasing prevalence of neck and back pain, growing geriatric population, and the growing demand for safe & effective cervical spondylosis treatment around the globe are expected to propel the growth of the global cervical spondylosis treatment market.

For instance, cervical spondylosis is a very common cause of myelopathy in the elderly. It is the most common spine dysfunction in elderly people. It is very common and worsens with age. More than 85% of people older than the age of 60 are affected by cervical spondylosis. Thus, with the growing geriatric population and the rising burden of cervical spondylosis, the demand for safe and effective cervical spondylosis treatment is also increasing. As per the World Health Organization (WHO), by 2030, one in six people in the world will be aged 60 years or over, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.

Key Features of the Study:

This report provides an in-depth analysis of the global cervical spondylosis treatment market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cervical spondylosis treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Novartis AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Sanofi S.A., Stryker Corporation, Zimmer Biomet Holdings, Inc., and Medtronic plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cervical spondylosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical spondylosis treatment market

Detailed Segmentation:

By Type of Treatment:
- Medication
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Muscle relaxants
- Antidepressants
- Others (Anti-seizure medications, etc.)
- Surgery
By Route of Administration:
- Oral
- Injection
- Topical
- Others (patches, etc.)
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Abbott Laboratories
- AstraZeneca Plc.
- Novartis AG
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Amgen Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline plc
- Johnson & Johnson Services, Inc.
- Sanofi S.A.
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Medtronic plc

Report Description
- Market Definition and Scope
Executive Summary
- Global Cervical Spondylosis Treatment Market, By Type of Treatment
- Global Cervical Spondylosis Treatment Market, By Route of Administration
- Global Cervical Spondylosis Treatment Market, By Distribution Channel
- Global Cervical Spondylosis Treatment Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Cervical Spondylosis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Cervical Spondylosis Treatment Market, By Type of Treatment, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Muscle relaxants
Antidepressants
Others
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Cervical Spondylosis Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Cervical Spondylosis Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Cervical Spondylosis Treatment Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
AstraZeneca Plc.
Novartis AG
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Amgen Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson Services, Inc.
Sanofi S.A.
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Medtronic plc